iBio, Inc.
IBIO· Nasdaq
IBIOiBio, Inc.
Filed Feb 14, 2012 · 10-Q · 45 days after period end · 0000930413-12-000910
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Revenue | $233.83K | — |
| Net Income | -$1.60M | -$4.71M |
| EPS Diluted | -$0.05 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Feb 14, 2012 · 45 d after period end
